Effects of a Highly Selective Acetylcholine-Activated K+ Channel Blocker on Experimental Atrial Fibrillation
Circulation: Arrhythmia and Electrophysiology - United States
doi 10.1161/circep.110.951608
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)